Mandrake Bio
PrivateLast Round
Pre Seed
Jul 16, 2026
Total Funding Raised
$1.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mandrake Bio operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Pre Seed round in July 2026.
Mandrake Bio is a biotechnology company that develops AI-powered protein design and gene-editing platforms for agricultural and medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mandrake Bio Comparables
Compare Mandrake Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Basecamp Research | 79% | |
| Profluent Bio | 79% | |
| Biomatter | 77% |
For institutional investors. Book with your work email.
Mandrake Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Mandrake Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DeVC | Pre Seed |
| Activate | Pre Seed |
| Antler India | Pre Seed |
| Antler | Pre Seed |
| Spectrum Impact | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$1.9M round led by Activate and Antler
- May 15, 2026
Grew 75% QoQ, from 4 to 7 employees.
For institutional investors. Book with your work email.
Mandrake Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mandrake Bio's valuation, stock price, and market status.
Is Mandrake Bio a public or private company?
Mandrake Bio is a private company.
What is the current stock price of Mandrake Bio?
Mandrake Bio is a private company, so its shares have no public market price. Caplight tracks Mandrake Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mandrake Bio worth (valuation)?
Valuation information for Mandrake Bio is not publicly available.
Can I buy Mandrake Bio stock?
Mandrake Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mandrake Bio's last funding round?
Mandrake Bio's most recent funding round was Pre Seed on July 16, 2026.
Who are the main investors in Mandrake Bio?
Key investors in Mandrake Bio include Activate, Antler India, Antler.
Will Mandrake Bio IPO soon?
No public IPO plans have been announced for Mandrake Bio.
How can I track Mandrake Bio secondary market activity?
Caplight tracks bids, offers, and trades in Mandrake Bio's shares on secondary markets.